|Dr. Michael Monsour||Exec. Chairman||82.12k||N/A||N/A|
|Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE||Chief Exec. Officer||282.88k||N/A||N/A|
|Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD||CFO & Exec. Director||192.72k||N/A||N/A|
|Ms. Chelsea Cornelius||Product Devel. & Operations Mang.||N/A||N/A||N/A|
|Ms. Megan Henken||VP of Global Marketing||N/A||N/A||N/A|
|Mr. Bryan Dulhunty C.A., BEc, ACA||Company Sec.||N/A||N/A||N/A|
Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.
Analytica Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.